Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral? Elliot Wakeam, MD, MPH, Joseph.

Slides:

Advertisements

Similar presentations

Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes Samuel Kim, MD, Harald C. Ott, MD, Cameron D. Wright, MD,

Advertisements

Left Video-Assisted Thoracoscopic Surgery Esophagectomy in a Patient With Situs Inversus Totalis and Kartagener Syndrome John Peel, BHSc, Gail Darling,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Chronic Obstructive Pulmonary Disease Impact Upon Outcomes: The Veterans Affairs Randomized On/Off Bypass Trial G. Hossein Almassi, MD, A. Laurie Shroyer,

The Society of Thoracic Surgeons Practice Guideline on the Prophylaxis and Management of Atrial Fibrillation Associated With General Thoracic Surgery:

Effect of Gastrointestinal Malformations on the Outcomes of Patients With Congenital Heart Disease Carlos M. Mery, MD, MPH, Luis E. De León, MD, J. Rubén.

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery Ming Liu, MS, MA, Charlotte M. Druschel,

Trevor Williams, MD, MPH, Brian C

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Comparison of Three Measurements of Cardiac Surgery Mortality for the Northern New England Cardiovascular Disease Study Group Donald S. Likosky, PhD,

Invited Commentary The Annals of Thoracic Surgery

Postoperative Pneumonia After Major Pulmonary Resections: An Unsolved Problem in Thoracic Surgery Dana M. Radu, MD, Françoise Jauréguy, Pharm D, Agathe.

The Effect of Institutional Volume on Complications and Their Impact on Mortality After Pediatric Heart Transplantation Cecillia Lui, MD, Joshua C. Grimm,

Loretta Erhunmwunsee, MD, Brian C

Hanan A. Tanash, PhD, Gerdt C. Riise, PhD, Magnus P

Emanuela Taioli, MD, PhD, Andrea S

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Reply The Annals of Thoracic Surgery

Quality Indicators for Non-Small Cell Lung Cancer Operations With Use of a Modified Delphi Consensus Process Gail Darling, MD, Richard Malthaner, MD,

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,

Katy A. Marino, MD, Jennifer L. Sullivan, MD, Benny Weksler, MD

Trevor Williams, MD, MPH, Brian C

Intrapleural Instillation of Autologous Blood for Persistent Air Leak in Spontaneous Pneumothorax in Patients With Advanced Chronic Obstructive Pulmonary.

The David V Valve-Sparing Root Replacement Provides Improved Survival Compared With Mechanical Valve-conduits in the Treatment of Young Patients With.

The Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes Damien J.

Who Do You Say You Are? The Annals of Thoracic Surgery

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Pulmonary Function Tests Overestimate Chronic Pulmonary Disease in Patients With Severe Aortic Stenosis Mitchell J. Magee, MD, Morley A. Herbert, PhD,

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Outcomes of Mechanical Valves in the Pulmonic Position in Patients With Congenital Heart Disease Over a 20-Year Period Hong Ju Shin, MD, Young-Hwue Kim,

Use of Amiodarone After Major Lung Resection

Management of Subcutaneous Emphysema After Pulmonary Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Lei Yu, MD, Tianxiang Gu, MD, PhD, Zongyi Xiu, MD, PhD

Terry Shih, MD, Justin B. Dimick, MD, MPH

The Utility of Electromagnetic Navigational Bronchoscopy as a Localization Tool for Robotic Resection of Small Pulmonary Nodules William D. Bolton, MD,

Pulmonary Resection for Lung Cancer in Octogenarians

Open, Video-Assisted Thoracic Surgery, and Robotic Lobectomy: Review of a National Database Michael Kent, MD, Thomas Wang, PhD, Richard Whyte, MD, Thomas.

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Lucas W. Thornblade, MD, Aaron M. Cheng, MD, Douglas E

Editorial Board, January 2010

Understanding Mortality as a Quality Indicator After Esophagectomy

William M. Whited, MD, Paul Henley, BS, Erin M

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD

Specialty Training and Mortality After Esophageal Cancer Resection

Impact of Functional Status on Survival After Coronary Artery Bypass Grafting in a Veteran Population Roberto Cervera, MD, Faisal G. Bakaeen, MD, Lorraine.

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Invited Commentary The Annals of Thoracic Surgery

Robert Lee Replogle, September 30, 1931–May 9, 2016

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Yinin Hu, MD, Timothy L. McMurry, PhD, Kristen M. Wells, PhD, James M

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Late Consequences of a Much Earlier Decision

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Overview of Lung Cancer Surgery in Ontario

Michael J. Weyant, MD, Manjit S

Michelle C. Wallace, MD, James Jaggers, MD, Jennifer S

Factors in the Selection and Management of Chest Tubes After Pulmonary Lobectomy: Results of a National Survey of Thoracic Surgeons Samuel S. Kim, MD,

Presentation transcript:

Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral? Elliot Wakeam, MD, MPH, Joseph A. Hyder, MD, PhD, Stuart R. Lipsitz, PhD, Gail E. Darling, MD, FRCSC, Samuel R.G. Finlayson, MD, MPH The Annals of Thoracic Surgery Volume 100, Issue 3, Pages 939-946 (September 2015) DOI: 10.1016/j.athoracsur.2015.03.076 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Adjusted volume-mortality relationship, by patient strata. Darkest blue bars indicate low volume; dark blue, moderate volume; medium blue, high volume; and light blue, very high volume. Asterisk (*) denotes significant trend. No significant trend is noted for patients in the 60 to 70 age group or in the less than 60 age group. (COPD = chronic obstructive pulmonary disease.) The Annals of Thoracic Surgery 2015 100, 939-946DOI: (10.1016/j.athoracsur.2015.03.076) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Adjusted cost-volume relationship, by patient strata. Darkest red bars indicate low volume; dark red, moderate volume; medium red, high volume; and light red, very high volume. (COPD = chronic obstructive pulmonary disease.) The Annals of Thoracic Surgery 2015 100, 939-946DOI: (10.1016/j.athoracsur.2015.03.076) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Cost-volume relationships. Dark gray bars indicate low volume; light gray, moderate volume; medium gray, high volume; and darkest gray, very high volume. (COPD = chronic obstructive pulmonary disease.) The Annals of Thoracic Surgery 2015 100, 939-946DOI: (10.1016/j.athoracsur.2015.03.076) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions